• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微泡性和大泡性脂肪变性的分子特征显示代谢途径存在广泛差异。

Molecular Characterization of Microvesicular and Macrovesicular Steatosis Shows Widespread Differences in Metabolic Pathways.

作者信息

Kristiansen Maria N B, Veidal Sanne S, Christoffersen Christina, Jelsing Jacob, Rigbolt Kristoffer T G

机构信息

Gubra Aps, Hørsholm Kongevej 11B, 2970 Hørsholm, Denmark.

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.

出版信息

Lipids. 2019 Jan;54(1):109-115. doi: 10.1002/lipd.12121. Epub 2019 Feb 5.

DOI:10.1002/lipd.12121
PMID:30723896
Abstract

Simple steatosis is the hallmark of nonalcoholic fatty liver disease, with lipid accumulating as either microvesicular or macrovesicular lipid droplets within hepatocytes. The present study used a combination of laser capture microdissection and RNAseq to characterize murine gene expression in nonsteatotic, microsteatotic, and macrosteatotic compartments collected from the same liver. The data indicate that microvesicular steatosis is intermediate to macrovesicular steatosis, showing a widespread and pronounced metabolic gene regulation of lipid export, gluconeogenesis, and de novo lipogenesis. Key enzymes, such as fatty acid synthase and fructose 1,6-bisphosphatase as well as apolipoprotein C-III, were identified to show clear expression differences between the compartments. Furthermore, increased expression of lipid particle formation genes provided a molecular description of the fusion of microsteatotic lipid compartments to produce macrosteatotic cells with a single enlarged lipid droplet.

摘要

单纯性脂肪变性是非酒精性脂肪性肝病的标志,脂质以微泡状或大泡状脂滴的形式在肝细胞内蓄积。本研究结合激光捕获显微切割和RNA测序技术,对取自同一肝脏的非脂肪变性、微脂肪变性和大脂肪变性区域的小鼠基因表达进行了表征。数据表明,微泡状脂肪变性介于大泡状脂肪变性之间,显示出脂质输出、糖异生和从头脂肪生成方面广泛且明显的代谢基因调控。已确定关键酶,如脂肪酸合酶、果糖1,6 -二磷酸酶以及载脂蛋白C-III,在不同区域表现出明显的表达差异。此外,脂质颗粒形成基因表达的增加为微脂肪变性脂质区域融合产生具有单个增大脂滴的大脂肪变性细胞提供了分子描述。

相似文献

1
Molecular Characterization of Microvesicular and Macrovesicular Steatosis Shows Widespread Differences in Metabolic Pathways.微泡性和大泡性脂肪变性的分子特征显示代谢途径存在广泛差异。
Lipids. 2019 Jan;54(1):109-115. doi: 10.1002/lipd.12121. Epub 2019 Feb 5.
2
Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.丙酮酸脱氢酶激酶4介导脂肪生成并促进非酒精性脂肪性肝炎的发病机制。
Biochem Biophys Res Commun. 2018 Jan 1;495(1):582-586. doi: 10.1016/j.bbrc.2017.11.054. Epub 2017 Nov 9.
3
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.肝脏脂质蓄积:血糖调节激素失调的原因及后果
J Endocrinol. 2017 Jul;234(1):R1-R21. doi: 10.1530/JOE-16-0513. Epub 2017 Apr 20.
4
Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis.改变营养底物会导致肝脂肪变性细胞模型中大型脂滴的积累和代谢改变。
Physiol Rep. 2020 Jul;8(13):e14482. doi: 10.14814/phy2.14482.
5
Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease.黑果腺肋花楸减轻非酒精性脂肪性肝病小鼠肝细胞中与从头脂肪生成相关基因的表达。
Nutr Res. 2016 Jan;36(1):57-64. doi: 10.1016/j.nutres.2015.10.010. Epub 2015 Oct 31.
6
Biomechanics of cultured hepatic cells during different steatogenic hits.培养肝细胞在不同成脂刺激下的生物力学特性。
J Mech Behav Biomed Mater. 2019 Sep;97:296-305. doi: 10.1016/j.jmbbm.2019.05.036. Epub 2019 May 22.
7
Review article: Hepatic steatosis and its associations with acute and chronic liver diseases.综述文章:肝脂肪变性及其与急性和慢性肝病的关系。
Aliment Pharmacol Ther. 2024 Jul;60(2):167-200. doi: 10.1111/apt.18059. Epub 2024 Jun 7.
8
Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.下调 miR-192 通过诱导 SREBF1 引起肝脂肪变性和脂质堆积:双酚 A 引发非酒精性脂肪性肝病的新机制。
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Sep;1862(9):869-882. doi: 10.1016/j.bbalip.2017.05.001. Epub 2017 May 5.
9
A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD.肝脏能量代谢的计算模型:理解非酒精性脂肪性肝病中的区域损伤和脂肪变性
PLoS Comput Biol. 2016 Sep 15;12(9):e1005105. doi: 10.1371/journal.pcbi.1005105. eCollection 2016 Sep.
10
Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.长链非编码 RNA lncSHGL 募集 hnRNPA1 以抑制肝脏糖异生和脂生成。
Diabetes. 2018 Apr;67(4):581-593. doi: 10.2337/db17-0799. Epub 2018 Jan 30.

引用本文的文献

1
Elongation factor 1A1 inhibition elicits changes in lipid droplet size, the bulk transcriptome, and cell type-associated gene expression in MASLD mouse liver.延长因子 1A1 抑制在 MASLD 小鼠肝脏中引起脂滴大小、整体转录组和细胞类型相关基因表达的变化。
Am J Physiol Gastrointest Liver Physiol. 2024 Oct 1;327(4):G608-G622. doi: 10.1152/ajpgi.00276.2023. Epub 2024 Aug 13.
2
Steatosis and Metabolic Disorders Associated with Synergistic Activation of the CAR/RXR Heterodimer by Pesticides.脂肪变性和代谢紊乱与农药协同激活 CAR/RXR 异二聚体有关。
Cells. 2023 Apr 21;12(8):1201. doi: 10.3390/cells12081201.
3
An Egg White-Derived Peptide Enhances Systemic Insulin Sensitivity and Modulates Markers of Non-Alcoholic Fatty Liver Disease in Obese, Insulin Resistant Mice.
一种源自蛋清的肽增强肥胖、胰岛素抵抗小鼠的全身胰岛素敏感性并调节非酒精性脂肪性肝病标志物。
Metabolites. 2023 Jan 24;13(2):174. doi: 10.3390/metabo13020174.
4
Microvesicular Steatosis in Individuals with Obesity: a Histological Marker of Non-alcoholic Fatty Liver Disease Severity.肥胖个体中的微小泡性脂肪变性:非酒精性脂肪性肝病严重程度的组织学标志物。
Obes Surg. 2023 Mar;33(3):813-820. doi: 10.1007/s11695-023-06467-9. Epub 2023 Jan 24.
5
Distinctive Features of Hepatic Steatosis in Children: Is It Primary or Secondary to Inborn Errors of Metabolism?儿童肝脂肪变性的显著特征:它是原发性的还是代谢先天性缺陷继发的?
Pediatr Gastroenterol Hepatol Nutr. 2021 Nov;24(6):518-527. doi: 10.5223/pghn.2021.24.6.518. Epub 2021 Nov 5.
6
Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations.用于管理胰岛素抵抗和肝脏代谢紊乱的糖巨肽
Biomedicines. 2021 Sep 2;9(9):1140. doi: 10.3390/biomedicines9091140.
7
Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor.肝脏中miR-192-3p的重新激活通过靶向糖皮质激素受体减轻脂肪变性。
JHEP Rep. 2020 Sep 6;2(6):100179. doi: 10.1016/j.jhepr.2020.100179. eCollection 2020 Dec.